Kuopio, Finland

Reino Laatikainen

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Flx Discoveries Oy. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reino Laatikainen. Retrieved from https://idiyas.com/inventor/reino-laatikainen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Reino Laatikainen

Introduction

Reino Laatikainen is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that interact with androgen receptors. His work has implications for both androgenic and antiandrogenic therapies.

Latest Patents

Reino Laatikainen holds a patent for "Non-steroidal compounds as androgen receptor modulators." This invention relates to novel 4,5-dihydroisoxazoles and 4,5-dihydro[1,2,4]-oxadiazoles of formula (I). These compounds are designed for use as androgenic or antiandrogenic agents or androgen receptor modulators, and the patent also details methods for their preparation. He has 1 patent to his name.

Career Highlights

Reino Laatikainen is associated with Flx Discoveries Oy, a company focused on innovative research and development in the field of pharmaceuticals. His work at the company has been instrumental in advancing the understanding of androgen receptor modulation.

Collaborations

Reino has collaborated with notable colleagues such as Tuomas Oravilahti and Jorma Palvimo. Their combined expertise has contributed to the success of their research initiatives.

Conclusion

Reino Laatikainen's innovative work in the field of androgen receptor modulators showcases his commitment to advancing pharmaceutical science. His contributions are paving the way for new therapeutic options in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…